查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541719

2024-2032 年按药物类别（唑类、棘白菌素类、多烯类、烯丙胺类等）、适应症（皮癣菌病、曲霉病、念珠菌病等）和地区分類的抗真菌药物市场报告

Antifungal Drugs Market Report by Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, and Others), Indication (Dermatophytosis, Aspergillosis, Candidiasis, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年全球抗真菌药物市场规模达151亿美元。

抗真菌药物，或称抗真菌药物，指用于治疗皮肤、头髮和指甲真菌感染的药物。一些常用的抗真菌药物包括多烯类、唑类和烯丙胺类。它们专门中和真菌剂和皮癣菌，例如念珠菌和绦虫，并有助于治疗脚气、癣、曲霉病、念珠菌病和真菌性脑膜炎。这些药物通常以非处方 (OTC) 胶囊、凝胶、液体和药丸形式提供，或直接注入血液中的静脉注射溶液，以最大程度地减少和预防真菌感染。

抗真菌药物市场趋势：

真菌和医院感染的日益流行是创造市场成长积极前景的关键因素之一。抗真菌药物可有效对抗因暴露于医院或潮湿环境中受污染的表面而引起的全身感染和表浅感染。此外，城乡地区非处方药的便捷取得也为市场成长提供了动力。随着大众健康意识的不断增强，消费者越来越多地选择非处方药来及时治疗轻微感染。此外，各种产品创新，例如用于治疗侵袭性真菌感染的合成和半合成唑类化合物的开发，也是其他生长诱导因素。药厂也广泛投资于喷雾剂、乳膏、片剂和注射剂等新型治疗药物的研发（R&D），以增强功效。其他因素，包括製药业的显着成长，以及促进公共卫生的有利政府政策的实施，预计将推动市场成长。

本报告回答的关键问题

  • 2023年全球抗真菌药物市场规模有多大？ 2024-2032年全球抗霉菌药物市场的预期成长率是多少？
  • COVID-19 对全球抗真菌药物市场有何影响？
  • 推动全球抗真菌药物市场的关键因素是什么？
  • 根据药物类别，全球抗真菌药物市场的细分情况如何？
  • 根据适应症，全球抗霉菌药物市场的细分如何？
  • 全球抗真菌药物市场的重点区域有哪些？
  • 全球抗真菌药物市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球抗真菌药物市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依药物类别

  • 唑类
    • 市场趋势
    • 关键环节
      • 伏立康唑（Vfend）
      • 泊沙康唑（诺沙非）
      • 克霉唑（Canesten）
      • 艾沙康唑 (CRESEMBA)
      • 其他的
    • 市场预测
  • 棘白菌素
    • 市场趋势
    • 关键环节
      • 卡泊芬净（Cancidas）
      • 米卡芬净（Mycamine/ Funguard）
      • 其他的
    • 市场预测
  • 多烯
    • 市场趋势
    • 关键环节
      • 两性霉素（AmBisome）
      • 其他的
    • 市场预测
  • 烯丙胺
    • 市场趋势
    • 关键环节
      • 特比萘芬（兰美抒）
      • 其他的
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依迹象

  • 皮癣菌病
    • 市场趋势
    • 市场预测
  • 曲菌病
    • 市场趋势
    • 市场预测
  • 念珠菌病
    • 市场趋势
    • 关键环节
      • 侵袭性念珠菌病
      • 外阴阴道念珠菌病 (VVC)
      • 口腔/喉咙/食道念珠菌病
      • 其他的
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 9 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第13章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Arcadia Consumer Healthcare Inc.
    • Astellas Pharma Inc.
    • Bayer AG
    • GlaxoSmithKline Plc
    • Merck & Co. Inc.
    • Merck KGaA
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
    • Scynexis Inc.
Product Code: SR112024A3933

The global antifungal drugs market size reached US$ 15.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 20.1 Billion by 2032, exhibiting a growth rate (CAGR) of 3.1% during 2024-2032.

Antifungal drugs, or antimycotic drugs, refer to the pharmaceutical medicines used for the treatment of fungal infections on skin, hair and nails. Some of the commonly used antifungal drugs include polyenes, azoles and allylamines. They specifically neutralize fungal agents and dermatophytes, such as candida and tapeworms, and aid in the treatment of athlete's foot, ringworm, aspergillosis, candidiasis and fungal meningitis. These drugs are commonly available in over the counter (OTC) capsule, gel, liquid and pill variants or intravenous solutions that are injected directly into the bloodstream to minimize and prevent fungal infection.

Antifungal Drugs Market Trends:

The increasing prevalence of fungal and nosocomial infections is one of the key factors creating a positive outlook for the market growth. Antifungal drugs are effective against both systemic and superficial infections that are acquired from exposure to contaminated surfaces in hospitals or humid conditions. Moreover, the convenient availability of OTC drugs in both urban and rural areas is providing a thrust to the market growth. With the rising health consciousness among the masses, consumers are increasingly opting for OTC therapeutics to timely treat minor infections. Additionally, various product innovations, such as the development of synthetic and semi-synthetic azole-based compounds for the treatment of invasive fungal infections, are acting as other growth-inducing factors. Pharmaceutical manufacturers are also investing extensively in the research and development (R&D) of novel therapeutics in the form of sprays, creams, tablets and injections with enhanced efficacy. Other factors, including significant growth in the pharmaceutical industry, along with the implementation of favorable government policies promoting public health, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global antifungal drugs market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on drug class and indication.

Breakup by Drug Class:

Azoles

Voriconazole (Vfend)

Posaconazole (Noxafil)

Clotrimazole (Canesten)

Isavuconazole (CRESEMBA)

Others

Echinocandins

Caspofungin (Cancidas)

Micafungin (Mycamine/ Funguard)

Others

Polyenes

Amphotericin (AmBisome)

Others

Allylamines

Terbinafine (Lamisil)

Others

Others

Breakup by Indication:

Dermatophytosis

Aspergillosis

Candidiasis

Invasive Candidiasis

Vulvovaginal Candidiasis (VVC)

Mouth/Throat/Esophageal Candidiasis

Others

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arcadia Consumer Healthcare Inc., Astellas Pharma Inc., Bayer AG, GlaxoSmithKline Plc, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Scynexis Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global antifungal drugs market in 2023?
  • 2. What is the expected growth rate of the global antifungal drugs market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global antifungal drugs market?
  • 4. What are the key factors driving the global antifungal drugs market?
  • 5. What is the breakup of the global antifungal drugs market based on the drug class?
  • 6. What is the breakup of the global antifungal drugs market based on the indication?
  • 7. What are the key regions in the global antifungal drugs market?
  • 8. Who are the key players/companies in the global antifungal drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Antifungal Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class

  • 6.1 Azoles
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Voriconazole (Vfend)
      • 6.1.2.2 Posaconazole (Noxafil)
      • 6.1.2.3 Clotrimazole (Canesten)
      • 6.1.2.4 Isavuconazole (CRESEMBA)
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Echinocandins
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Caspofungin (Cancidas)
      • 6.2.2.2 Micafungin (Mycamine/ Funguard)
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast
  • 6.3 Polyenes
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Amphotericin (AmBisome)
      • 6.3.2.2 Others
    • 6.3.3 Market Forecast
  • 6.4 Allylamines
    • 6.4.1 Market Trends
    • 6.4.2 Key Segments
      • 6.4.2.1 Terbinafine (Lamisil)
      • 6.4.2.2 Others
    • 6.4.3 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Dermatophytosis
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Aspergillosis
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Candidiasis
    • 7.3.1 Market Trends
    • 7.3.2 Key Segments
      • 7.3.2.1 Invasive Candidiasis
      • 7.3.2.2 Vulvovaginal Candidiasis (VVC)
      • 7.3.2.3 Mouth/Throat/Esophageal Candidiasis
      • 7.3.2.4 Others
    • 7.3.3 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Arcadia Consumer Healthcare Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Astellas Pharma Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Bayer AG
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 GlaxoSmithKline Plc
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Merck & Co. Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Merck KGaA
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Novartis AG
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Pfizer Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Sanofi S.A.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Scynexis Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials

List of Figures

  • Figure 1: Global: Antifungal Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Antifungal Drugs Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Antifungal Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Antifungal Drugs Market: Breakup by Drug Class (in %), 2023
  • Figure 5: Global: Antifungal Drugs Market: Breakup by Indication (in %), 2023
  • Figure 6: Global: Antifungal Drugs Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Antifungal Drugs (Azoles) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Antifungal Drugs (Azoles) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Antifungal Drugs (Echinocandins) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Antifungal Drugs (Echinocandins) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Antifungal Drugs (Polyenes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Antifungal Drugs (Polyenes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Antifungal Drugs (Allylamines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Antifungal Drugs (Allylamines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Antifungal Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Antifungal Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Antifungal Drugs (Dermatophytosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Antifungal Drugs (Dermatophytosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Antifungal Drugs (Aspergillosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Antifungal Drugs (Aspergillosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Antifungal Drugs (Candidiasis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Antifungal Drugs (Candidiasis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Antifungal Drugs (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Antifungal Drugs (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: North America: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: North America: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: United States: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: United States: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Canada: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Canada: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Asia-Pacific: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Asia-Pacific: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: China: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: China: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Japan: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Japan: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: India: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: India: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: South Korea: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: South Korea: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Australia: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Australia: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Indonesia: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Indonesia: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Others: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Others: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Europe: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Europe: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Germany: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Germany: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: France: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: France: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: United Kingdom: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: United Kingdom: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Italy: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Italy: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Spain: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Spain: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Russia: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Russia: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Others: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Others: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Latin America: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Latin America: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Brazil: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Brazil: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Mexico: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Mexico: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Others: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Others: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Middle East and Africa: Antifungal Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Middle East and Africa: Antifungal Drugs Market: Breakup by Country (in %), 2023
  • Figure 73: Middle East and Africa: Antifungal Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Global: Antifungal Drugs Industry: SWOT Analysis
  • Figure 75: Global: Antifungal Drugs Industry: Value Chain Analysis
  • Figure 76: Global: Antifungal Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Antifungal Drugs Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Antifungal Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
  • Table 3: Global: Antifungal Drugs Market Forecast: Breakup by Indication (in Million US$), 2024-2032
  • Table 4: Global: Antifungal Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Antifungal Drugs Market: Competitive Structure
  • Table 6: Global: Antifungal Drugs Market: Key Players